“…Autoimmunity is driven by Th17 cells and ameliorated or prevented by antigen-specific regulatory T cells. In the Du et al, 2005;Fritsche et al, 2007;Kostyuk et al, 2012;John et al, 2013Smith et al, 2013 Circadian rhythmicity Mukai and Tischkau, 2007 Expression of AhR target genes Wei et al, 2000;Oberg et al, 2005;Sciullo et al, 2008;Nair et al, 2009;Wincent et al, 2009;Lee et al, 2010;Luecke et al, 2010;Mohammadi-Bardbori et al, 2012;Rico-Leo et al, 2013;Sumida et al, 2013Jönsson et al, 2009Laub et al, 2010;Wincent et al, 2012;Odio et al, 2013 Genome rearrangement Okudaira et al, 2010Okudaira et al, , 2013 Immune response Apetoh et al, 2010;Bankoti et al, 2010Quintana et al, 2008Veldhoen et al, 2008;Martin et al, 2009;Monteleone et al, 2011;Jeong et al, 2012;Pauly et al, 2012;Qiu et al, 2012;Sibilano et al, 2012;Duarte et al, 2013;Wheeler et al, 2013;Zhou et al, 2013 Nuclear receptor cross-talk Ekins et al, 2008;Reschly et al, 2008;Bunaciu and Yen, 2013 AhR activation can also occur by factors that block/inhibit CYP1A, leading to exceptionally high FICZ levels because FICZ is no longer degraded. In both scenarios (B) and (C), FICZ homeostastic...…”